Pioneering Study Reveals No Increased Pneumonia Risk in COPD Patients Using Extrafine Beclometasone Dipropionate in Inhaler Therapy
Observational and Pragmatic Research International Joins the Good Business Charter
LANDMARK STUDY REVEALS ADVERSE OUTCOMES LINKED TO ORAL CORTICOSTEROID USE IN COPD PATIENTS
New inventory of severe asthma registries unlocks potential for global research and best care
A greater number of comorbidities is associated with poorer outcomes among adults with severe asthma
Opportunities to Optimize High-risk COPD Management Persist in US Primary Care
Biologics dramatically reduce steroid requirements and exacerbation rates in severe asthma patients
CONQUEST Shines Spotlight on Opportunities to Enhance Cardiopulmonary Outcomes Among High-risk COPD